Last updated: 12 February 2024 at 4:45pm EST

Dr. Theresa G. Wingrove Net Worth




The estimated Net Worth of Theresa Wingrove is at least $4.81 Million dollars as of 2 February 2024. Dr Wingrove owns over 29,640 units of Immunogen stock worth over $1,032,982 and over the last 13 years he sold IMGN stock worth over $3,230,837. In addition, he makes $548,205 as Sr. VP of Regulatory Affairs & Quality at Immunogen.

Dr Wingrove IMGN stock SEC Form 4 insiders trading

Dr has made over 12 trades of the Immunogen stock since 2014, according to the Form 4 filled with the SEC. Most recently he exercised 29,640 units of IMGN stock worth $925,954 on 2 February 2024.

The largest trade he's ever made was selling 192,013 units of Immunogen stock on 15 September 2023 worth over $2,964,681. On average, Dr trades about 31,140 units every 102 days since 2011. As of 2 February 2024 he still owns at least 33,066 units of Immunogen stock.

You can see the complete history of Dr Wingrove stock trades at the bottom of the page.





Dr. Theresa G. Wingrove biography

Dr. Theresa G. Wingrove is the Sr. VP of Regulatory Affairs & Quality at Immunogen.

What is the salary of Dr Wingrove?

As the Sr. VP of Regulatory Affairs & Quality of Immunogen, the total compensation of Dr Wingrove at Immunogen is $548,205. There are 5 executives at Immunogen getting paid more, with Mark Enyedy having the highest compensation of $3,917,560.



How old is Dr Wingrove?

Dr Wingrove is 63, he's been the Sr. VP of Regulatory Affairs & Quality of Immunogen since . There are 4 older and 12 younger executives at Immunogen. The oldest executive at Immunogen, Inc. is Richard Wallace, 68, who is the Independent Director.

What's Dr Wingrove's mailing address?

Theresa's mailing address filed with the SEC is C/O IMMUNOGEN, INC., 830 WINTER STREET, WALTHAM, MA, 02451.

Insiders trading at Immunogen

Over the last 21 years, insiders at Immunogen have traded over $72,947,831 worth of Immunogen stock and bought 303,125 units worth $974,603 . The most active insiders traders include Biochem Incshire Pharmaceut..., Capital, L.P.Morton Holding..., and Mark J Enyedy. On average, Immunogen executives and independent directors trade stock every 34 days with the average trade being worth of $2,554,057. The most recent stock trade was executed by Stacy Ann Coen on 2 February 2024, trading 14,350 units of IMGN stock currently worth $448,294.



What does Immunogen do?

immunogen is a clinical-stage biotechnology company that develops targeted anticancer therapeutics with its proprietary antibody-drug conjugate (adc) technology. the company's lead product candidate, mirvetuximab soravtansine, is a potential treatment for folate receptor α-positive ovarian cancers and other solid tumors. leading healthcare companies have licensed rights to use immunogen's technology to develop novel anticancer therapies, and roche's marketed product, kadcyla, utilizes immunogen's adc technology. more information about the company can be found at www.immunogen.com.



What does Immunogen's logo look like?

Immunogen, Inc. logo

Complete history of Dr Wingrove stock trades at Immunogen

Date
#
Company
Insider
Trans.
Transaction
Shares Price per share Total value Shares after Source
2 Feb 2024 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Option 29,640 $29.26 $867,266
2 Feb 2024
33,066
16 Jan 2024 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Option 187,667 $5.13 $962,732
16 Jan 2024
191,093
15 Dec 2023 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Option 117,445 $5.14 $603,667
15 Dec 2023
120,256
29 Nov 2023 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Option 171,216 $10.68 $1,828,587
29 Nov 2023
167,235
15 Nov 2023 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Option 166,725 $4.55 $758,599
15 Nov 2023
169,536
7 Nov 2023 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Option 19,517 $10.65 $207,856
7 Nov 2023
22,328
16 Oct 2023 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Option 192,004 $4.55 $873,618
16 Oct 2023
194,815
15 Sep 2023 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Sale 192,013 $15.44 $2,964,681
15 Sep 2023
2,811
24 Feb 2020 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Sale 16,147 $4.99 $80,574
24 Feb 2020
70,498
22 Feb 2019 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Sale 11,032 $5.60 $61,779
22 Feb 2019
81,883
21 Feb 2018 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Sale 11,379 $10.88 $123,804
21 Feb 2018
90,671
10 Jan 2014 Theresa Wingrove
SVP OF REGULATORY AFFAIRS
Option 6,250 $9.85 $61,563
10 Jan 2014
6,250


Immunogen executives and stock owners

Immunogen executives and other stock owners filed with the SEC include: